40岁以下年轻患者的颅底浆细胞瘤:放射学视角和临床结果。

IF 1.5 Q4 ONCOLOGY
Cancer reports Pub Date : 2024-07-05 DOI:10.1002/cnr2.2106
Hesham Elsabah, Rola Ghasoub, Dina S. Soliman, Feryal Ibrahim, Mahmood B. Aldapt, Ruba Y. Taha, Safaa Al Azawi, Deena Mudawi, Abbas Moustafa, Halima Elomri, Honar Cherif
{"title":"40岁以下年轻患者的颅底浆细胞瘤:放射学视角和临床结果。","authors":"Hesham Elsabah,&nbsp;Rola Ghasoub,&nbsp;Dina S. Soliman,&nbsp;Feryal Ibrahim,&nbsp;Mahmood B. Aldapt,&nbsp;Ruba Y. Taha,&nbsp;Safaa Al Azawi,&nbsp;Deena Mudawi,&nbsp;Abbas Moustafa,&nbsp;Halima Elomri,&nbsp;Honar Cherif","doi":"10.1002/cnr2.2106","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Plasmacytoma of the skull base is a rare manifestation of plasma cell neoplasm with only a few cases documented in literature involving young adults. Plasmacytoma can be an isolated solitary lesion or a secondary manifestation of multiple myeloma (MM). In this study, we report the clinical and radiological characteristics, management, and outcomes of patients under the age of 40 who presented with skull base plasmacytoma and associated neurological manifestations. Additionally, we share our experience in treating a rare case of skull base plasmacytoma diagnosed during pregnancy, in which the patient exhibited a favorable response to myeloma treatment initiated after delivery.</p>\n </section>\n \n <section>\n \n <h3> Case Series</h3>\n \n <p>Four patients were identified, comprising one pregnant female and three male patients, with a median age of 36 years (range 33–37 years). The main presenting symptoms were headache, dizziness, and cranial nerve palsy. All patients received underwent systemic myeloma therapy and radiotherapy with three patients also underwent autologous stem cell transplantation (ASCT). Notably, all patients achieved complete remission.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Skull base plasmacytoma represents a rare manifestation of plasma cell neoplasms, underscoring the importance of considering it in the differential diagnosis of skull base lesions to ensure early intervention and avoid potential serious complications. Throughout our series, the cornerstone of therapy involved radiotherapy, systemic myeloma therapy, and ASCT, all of which elicited a favorable response in every case.</p>\n </section>\n </div>","PeriodicalId":9440,"journal":{"name":"Cancer reports","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11224911/pdf/","citationCount":"0","resultStr":"{\"title\":\"Skull base plasmacytoma in young patients aged below 40 years: Radiological perspectives and clinical outcomes\",\"authors\":\"Hesham Elsabah,&nbsp;Rola Ghasoub,&nbsp;Dina S. Soliman,&nbsp;Feryal Ibrahim,&nbsp;Mahmood B. Aldapt,&nbsp;Ruba Y. Taha,&nbsp;Safaa Al Azawi,&nbsp;Deena Mudawi,&nbsp;Abbas Moustafa,&nbsp;Halima Elomri,&nbsp;Honar Cherif\",\"doi\":\"10.1002/cnr2.2106\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Plasmacytoma of the skull base is a rare manifestation of plasma cell neoplasm with only a few cases documented in literature involving young adults. Plasmacytoma can be an isolated solitary lesion or a secondary manifestation of multiple myeloma (MM). In this study, we report the clinical and radiological characteristics, management, and outcomes of patients under the age of 40 who presented with skull base plasmacytoma and associated neurological manifestations. Additionally, we share our experience in treating a rare case of skull base plasmacytoma diagnosed during pregnancy, in which the patient exhibited a favorable response to myeloma treatment initiated after delivery.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Case Series</h3>\\n \\n <p>Four patients were identified, comprising one pregnant female and three male patients, with a median age of 36 years (range 33–37 years). The main presenting symptoms were headache, dizziness, and cranial nerve palsy. All patients received underwent systemic myeloma therapy and radiotherapy with three patients also underwent autologous stem cell transplantation (ASCT). Notably, all patients achieved complete remission.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Skull base plasmacytoma represents a rare manifestation of plasma cell neoplasms, underscoring the importance of considering it in the differential diagnosis of skull base lesions to ensure early intervention and avoid potential serious complications. Throughout our series, the cornerstone of therapy involved radiotherapy, systemic myeloma therapy, and ASCT, all of which elicited a favorable response in every case.</p>\\n </section>\\n </div>\",\"PeriodicalId\":9440,\"journal\":{\"name\":\"Cancer reports\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-07-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11224911/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cnr2.2106\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cnr2.2106","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:颅底浆细胞瘤是浆细胞肿瘤的一种罕见表现,文献中仅有少数涉及青壮年的病例。浆细胞瘤可能是孤立的单发病变,也可能是多发性骨髓瘤(MM)的继发表现。在本研究中,我们报告了 40 岁以下颅底浆细胞瘤患者的临床和放射学特征、治疗方法和结果,以及相关的神经系统表现。此外,我们还分享了治疗一例罕见的妊娠期颅底浆细胞瘤的经验,该患者对产后开始的骨髓瘤治疗反应良好:病例系列:共发现四名患者,其中一名为孕妇,三名为男性,中位年龄为36岁(33-37岁)。主要表现症状为头痛、头晕和颅神经麻痹。所有患者都接受了全身骨髓瘤治疗和放疗,其中三名患者还接受了自体干细胞移植(ASCT)。值得注意的是,所有患者都获得了完全缓解:颅底浆细胞瘤是浆细胞肿瘤的一种罕见表现,强调了在颅底病变的鉴别诊断中将其考虑在内的重要性,以确保早期干预并避免潜在的严重并发症。在我们的整个治疗系列中,放疗、全身骨髓瘤治疗和 ASCT 是治疗的基石,所有这些治疗方法都在每个病例中产生了良好的反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Skull base plasmacytoma in young patients aged below 40 years: Radiological perspectives and clinical outcomes

Skull base plasmacytoma in young patients aged below 40 years: Radiological perspectives and clinical outcomes

Background

Plasmacytoma of the skull base is a rare manifestation of plasma cell neoplasm with only a few cases documented in literature involving young adults. Plasmacytoma can be an isolated solitary lesion or a secondary manifestation of multiple myeloma (MM). In this study, we report the clinical and radiological characteristics, management, and outcomes of patients under the age of 40 who presented with skull base plasmacytoma and associated neurological manifestations. Additionally, we share our experience in treating a rare case of skull base plasmacytoma diagnosed during pregnancy, in which the patient exhibited a favorable response to myeloma treatment initiated after delivery.

Case Series

Four patients were identified, comprising one pregnant female and three male patients, with a median age of 36 years (range 33–37 years). The main presenting symptoms were headache, dizziness, and cranial nerve palsy. All patients received underwent systemic myeloma therapy and radiotherapy with three patients also underwent autologous stem cell transplantation (ASCT). Notably, all patients achieved complete remission.

Conclusion

Skull base plasmacytoma represents a rare manifestation of plasma cell neoplasms, underscoring the importance of considering it in the differential diagnosis of skull base lesions to ensure early intervention and avoid potential serious complications. Throughout our series, the cornerstone of therapy involved radiotherapy, systemic myeloma therapy, and ASCT, all of which elicited a favorable response in every case.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Cancer reports
Cancer reports Medicine-Oncology
CiteScore
2.70
自引率
5.90%
发文量
160
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信